Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Neurosciences

19-NEU-461-opioid-consortium-450×650

Opioid Consortium Takes a Regional Approach to Turn the Tide in Addiction Epidemic

What we've contributed, gained and learned through the partnership

19-NEU-504-Go!-to-Sleep-650×450

Online Cognitive Behavioral Therapy Tool Combats Insomnia in Chronic Disease Patients

‘Go! To Sleep’ CBT-I program brings insomnia therapy close to home

19-NEU-456_650x450_International Lewy Body Dementia Conference_2
May 15, 2019/Geriatrics

International Lewy Body Dementia Conference Comes to Las Vegas in June

Global experts share latest science, gather with patients and caregivers

19-NEU-158-benzelSurg-650×450

Benzel Symposium Launched AANS Meeting with Reflections on Spine Care — and an Eye to the Future

Neurosurgery luminaries share a generation’s worth of experience and wisdom

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

650×450-Distressed-Teen
May 10, 2019/Neurosciences

Higher Healthcare Costs Reported in Children with Co-Occurring Medical and Mental Health Conditions

Integrated care improves outcomes and reduces costs

19-NEU-321-excessive-sleepiness-650×450

Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial

New drug for adults with OSA or narcolepsy expected to launch soon

19-NEU-320-RNS-neurostimulation-650×450

Seizure Reductions with Responsive Neurostimulation Grow Over Time, Long-Term Study Shows

75% median reduction in seizures observed over 9 years of treatment

19-NEU-322-immunosuppression-650×450
May 7, 2019/Cancer

Degree of Immunosuppression Predicts Glioblastoma Prognosis, Temozolomide Studies Suggest

Experience to date highlights need for immunotherapy focus

19-NEU-325-deep-gray-matter_650x450

Assessing Deep Gray Matter Atrophy as a Predictor of Clinical Disability in MS

Study finds strong association between brain/thalamic volume and T2 lesion volume

19-NEU-326-multiple-sclerosis-650×450

Highly Effective Therapies Used in Only a Minority of Relapsing MS Cases, Study Finds

Prescribing practices analyzed over 12+ years across 10 sites

BackPage 57 of 113Next

Advertisement

Ad